Delivery Order SPE2DB22D3501-SPE2DB25FVM58
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$45K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,295,902 units of the prescription medication Dupixent 300 mg/2 ml pen (2 ml). The contract has a firm fixed price of $20,064.68 and an ultimate completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up...
This is a $36,916.53 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the drug Dupixent 300 mg/2 ml pen, with a period of performance through April 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing pharmaceutical products...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,709.46, is for the supply of Dupixent 300 mg/2 ml pens, a medication used to treat certain medical conditions. The award is not set-aside and has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,820,356 units of the medication Dupixent 300 mg/2 ml pen. The contract has a firm fixed price of $72,774.35 and a completion date of September 17, 2024. This order is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a $10,618.06 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a large pharmaceutical distributor. The contract is for the supply of 4,565,295,219 units of the specialty medication Dupixent 300 mg/2 ml pens, with a period of performance through July 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a $28,351.01 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,924,502 units of the drug Dupixent 300 mg/2 mL pen. This order was placed under an existing Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a broad range of medical commodities to support military treatment facilities and programs...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $17,763.93, is for the supply of the prescription medication Dupixent 300 mg/2 ml pen (2 ml). The contract has an ultimate completion date of May 1, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,068.71, is for the delivery of 4,566,487,436 units of the medication Dupixent 300 mg/2 ml pen. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of November 20, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,652.35 contract is for the delivery of Dupixent 300 mg/2 ml pen syringes to support military healthcare programs. The contract has an ultimate completion date of December 12, 2023 and was awarded on December 11, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,546.03, is for the supply of 4,568,078,563 units of the prescription medication Dupixent 300 mg/2 ml pen. The contract has an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. The...